Author | Sanoj Punnen, MD, MAS

Articles

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

June 19, 2019

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.